Abbreviations
The following are abbreviations commonly used in CIBMTR newsletter articles.
|
Abbreviation |
Meaning |
|---|---|
| ACT | adoptive cellular therapy |
|
ALL |
acute lymphoblastic leukemia or acute lymphocytic leukemia |
|
AML |
acute myeloid leukemia |
|
ASCO |
American Society of Clinical Oncology |
|
ASH |
American Society of Hematology |
|
ASTCT |
American Society for Transplantation and Cellular Therapy (formerly ASBMT - American Society of Blood and Marrow Transplantation) |
|
ATG |
anti-thymocyte globulin |
|
BMI |
body mass index |
|
BMT |
blood or bone marrow transplant / transplantation |
|
BMT CTN |
Blood and Marrow Transplant Clinical Trials Network |
|
CAR |
chimeric antigen receptor |
| CI | confidence interval |
|
CIBMTR |
Center for International Blood and Marrow Transplant Research |
|
CIDR |
Cellular Immunotherapy Data Resource |
|
CLL |
chronic lymphocytic leukemia |
|
CME |
continuing medical education |
|
CML |
chronic myeloid leukemia |
|
CMS |
Centers for Medicare and Medicaid Services |
|
CMV |
cytomegalovirus |
|
CPI |
continuous process improvement |
|
CRC |
Clinical Research Coordinator |
|
CRF |
Comprehensive Report Form |
|
CRID |
CIBMTR Research ID (a unique identifier for a patient) |
|
CRO |
contract research organization |
|
CRO Services |
CIBMTR Clinical Research Organization Services, formerly known as the Resource for Clinical Investigations in Blood and Marrow Transplantation (RCI BMT) |
|
CV |
curriculum vitae |
|
DBtC |
Data Back to Centers |
|
DHHS |
Department of Health and Human Services |
|
DLI |
donor leukocyte infusion |
|
DNA |
deoxyribonucleic acid |
|
DTI |
Data Transformation Initiative |
|
EHR |
electronic health record |
|
EMR |
electronic medical record |
|
ePRO |
electronic patient reported outcomes (system used by CIBMTR) |
|
FACT |
Foundation for the Accreditation of Cellular Therapy |
|
FDA |
Food and Drug Administration |
|
GCSF |
granulocyte colony-stimulating factor |
|
GI |
gastrointestinal |
|
GVHD |
graft-versus-host disease |
|
HCT |
hematopoietic cell transplant / transplantation |
|
HIV |
human immunodeficiency virus |
|
HLA |
human leukocyte antigen |
|
HR |
hazard ratio |
|
HRSA |
Health Resources and Services Administration |
|
IBMTR |
International Bone Marrow Transplant Registry |
|
ICU |
intensive care unit |
|
IDE |
investigational device exception |
|
IOTN |
Immuno-Oncology Transplantation Network |
|
IND |
investigational new drug |
|
IRB |
institutional review boards |
|
IT |
Information Technology |
|
KIR |
killer-cell immunoglobulin-like receptor |
|
MAC |
myeloablative conditioning |
|
MDS |
myelodysplastic syndrome |
|
MMUD |
mismatched, unrelated donor |
|
MPN |
myeloproliferative neoplasms |
|
MRD |
minimal residual disease |
|
NCCN |
National Comprehensive Cancer Network |
|
NCI |
National Cancer Institute |
|
NHL |
non-Hodgkin lymphoma |
|
NHLBI |
National Heart, Lung, and Blood Institute |
|
NIAID |
National Institute of Allergy and Infectious Disease |
|
NIH |
National Institutes of Health |
|
NK cells |
natural killer cells |
| PASS | post-authorization safety study |
|
PBSC |
peripheral blood stem cell |
|
PCORI |
Patient-Centered Outcomes Research Institute |
|
PI |
principal investigator |
|
PRO |
patient-reported outcomes |
|
PTCTC |
Pediatric Transplant and Cellular Therapy Consortium |
| QOL | quality of life |
|
RCI BMT |
Resource for Clinical Investigations in Blood and Marrow Transplantation, now known as CIBMTR CRO Services (see above) |
|
RFI |
request for information |
|
RIC |
reduced-intensity conditioning |
| SAA | severe aplastic anemia |
|
SCTOD |
Stem Cell Therapeutic Outcomes Database |
|
Tandem Meetings |
Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR |
|
TED |
Transplant Essential Data |
|
TKI |
tyrosine kinase inhibitors |
|
UCBT |
umbilical cord blood transplantation |
|
US |
United States of America |
|
URD |
unrelated donor |
|
WC |
Working Committee |
|
WMDA |
World Marrow Donor Association |